$AKBA Akebia Therapeutics Inc (NASDAQ:AKBA) Q3 2020 Earnings Call Nov 5, 2020, ____________________ Ally Bratzel -- Piper Sandler -- Analyst _____________________ Okay. Thanks. And maybe just one more question. Now that you've had the pre-NDA meeting with FDA, have your thoughts on the chances for an Adcom for vadadustat changed? And just maybe clarify, in your view, is this at all dependent or even related to the approval decision for roxadustat in non-dialysis and pre-dialysis next month? __________________________ John Butler -- President and Chief Executive Officer ________________________ Yes. I mean, I really can't comment on roxadustat. I think we're all going to know what happens there in six weeks or so. ______________________
  • 3
3 Likes